The use of octreotide to manage symptoms of bronchorrhea: a case report
- PMID: 24035070
- PMCID: PMC4343310
- DOI: 10.1016/j.jpainsymman.2013.06.008
The use of octreotide to manage symptoms of bronchorrhea: a case report
Abstract
Octreotide, a synthetic analogue of the hormone somatostatin, is primarily used in palliative medicine because of its antisecretory effect and has been shown to be effective in the management of bowel obstruction, nausea, and diarrhea. Octreotide also has been successfully used for the management of bronchorrhea in both inpatient and outpatient settings. We report the case of a 47-year-old female with a history of bronchioloalveolar cell carcinoma whose copious bronchial secretions were controlled with octreotide. Octreotide should be further evaluated as a first-line treatment for bronchorrhea.
Keywords: Bronchorrhea; bronchioloalveolar carcinoma; octreotide.
Published by Elsevier Inc.
Conflict of interest statement
No funding was received for this study, and the authors declare no conflicts of interest.
References
-
- Read WL, Page NC, Tierney RM, Piccirillo JF, Govindan R. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer. 2004;45:137–142. - PubMed
-
- Groneberg DA, Eynott PR, Oates T, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med. 2002;96:81–86. - PubMed
-
- Popat N, Raghavan N, McIvor RA. Severe bronchorrhea in a patient with bronchioloalveolar carcinoma. Chest. 2012;141:513–514. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical